Study group, n (%)

All

R+D+ (a)

R+D- (b)

R-D+ (c)

R-D- (d)

p value

1,339 (100)

263 (19.6)

162 (12.1)

197 (14.7)

717 (53.5)

(a) vs. (b)^*

Demographics, n (%)

Age, mean (SD)

68.0 (8.7)

70.2 (7.9)

71.8 (7.7)

68.4 (8.0)

66.3 (9.0)

Women

697 (52.1)

113 (43.0)

75 (46.3)

118 (59.9)

391 (54.5)

Arabs

154 (11.5)

39 (14.8)

15 (9.3)

25 (12.7)

75 (10.5)

Comorbidities, n (%)

IHD

409 (30.5)

119 (45.2)

54 (33.3)

58 (29.4)

178 (24.8)

0.0152

PVD

75 (5.6)

34 (12.9)

6 (3.7)

10 (5.1)

25 (3.5)

0.0016

Hypertension

934 (69.8)

237 (90.1)

116 (71.6)

153 (77.7)

428 (59.7)

0.0348

Diabetes

621 (46.4)

176 (66.9)

77 (47.5)

92 (46.7)

276 (38.5)

< 0.001

Dementia

89 (6.6)

26 (9.9)

13 (8.0)

20 (10.2)

30 (4.2)

BMI, mean (SD)

28.2 (5.5)

28.6 (6.0)

27.7 (5.2)

28.4 (5.8)

28.2 (5.3)

AF

169 (12.6)

54 (20.5)

32 (19.8)

25 (12.7)

58 (8.1)

Medications, n (%)

OAC†

183 (13.7)

56 (21.3)

30 (18.5)

32 (16.2)

65 (9.1)

OAC with AF

117 (69.2)

43 (79.6)

21 (65.6)

18 (72.0)

35 (60.3)

Any anti-platelets^‡

1,005 (75.1)

251 (95.4)

127 (78.4)

175 (88.8)

452 (63.0)

< 0.001

Any anti-thrombotic^§

1,016 (75.9)

254 (96.6)

130 (80.2)

175 (88.8)

457 (63.7)

PVD/IHD with ASA

476 (35.6)

148 (56.3)

63 (38.9)

71 (36.0)

194 (27.1)

< 0.001

Statins

1,068 (79.8)

243 (92.4)

134 (82.7)

176 (89.3)

515 (71.8)

0.0022